PERRIGO CO
NT 10-Q, 1998-11-17
PHARMACEUTICAL PREPARATIONS
Previous: CHARTER ONE FINANCIAL INC, S-8, 1998-11-17
Next: PERRIGO CO, 8-K, 1998-11-17



<PAGE>   1



SEC FILE NUMBER:  0-19725                              CUSIP NUMBER: 714290 10 3


                                 FORM 12B-25
                         NOTIFICATION OF LATE FILING

                                (Check One):
[ ] Form 10-K    [ ] Form 20-F   [ ] Form 11-K    [X] Form 10-Q   [ ] Form N-SAR

For Period Ended:  October 3, 1998

[   ]  Transition Report on Form 10-K
[   ]  Transition Report on Form 10-F
[   ]  Transition Report on Form 11-K
[   ]  Transition Report on Form 10-Q
[   ]  Transition Report on Form N-SAR


For the Transition Period Ended:

Read Attached Instruction Sheet Before Preparing Form.  Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:


                       PART I - REGISTRANT INFORMATION


FULL NAME OF REGISTRANT (FORMER NAME IF APPLICABLE)

     Perrigo Company

ADDRESS OF PRINCIPAL EXECUTIVE OFFICE (STREET AND NUMBER)

     515 Eastern Avenue

CITY, STATE AND ZIP CODE

     Allegan, Michigan  49010



                                      1

<PAGE>   2



                     PART II - RULES 12B-25 (B) AND (C)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25 (b) [Paragraph 23,047],
the following should be completed.  (Check box if appropriate).

[ x ] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;

[ x ] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on
or before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date; and [Amended in Release No. 34-26589 (Paragraph 72,435), effective April
12, 1989, 54 F.R. 10306.]

[   ] (c) The accountant's statement or other exhibit required by Rule 12b-25
(c) has been attached if applicable.


                            PART III - NARRATIVE

State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q,
N-SAR or the transition report or portion thereof could not be filed within the
prescribed period.  [Amended in Release No. 34-26589 (Paragraph 72,435),
effective April 12, 1989, 54 F.R. 10306.]

Perrigo Company (the "Company") converted its database to a new software system
and began using the system in the first quarter of fiscal year 1999.  Due to
the start-up time associated with this conversion, the Company believes that
the timeframe of the extension period is necessary to ensure that all financial
information is reviewed and properly stated.

                         PART IV - OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this
     notification.

     Thomas J. Ross               (616)  673-9125
     --------------               ---------------
     (Name)                 (Area Code)(Telephone Number)

(2)  Have all other periodic reports required under section 13 or 15 (d) of
     the Securities Exchange Act of 1934 or section 30 of the Investment
     Company Act of 1940 during the preceding 12 months or for such shorter
     period that the Registrant was required to file such report(s) been filed?
     If the answer is no, identify report(s).
                                                   [x]  Yes [ ] No



                                      2


<PAGE>   3




(3)  Is it anticipated that any significant change in results of operations
     from the corresponding period for the last fiscal year will be reflected
     by the earnings statements to be included in the subject report or portion
     thereof?

                                                   [  ] Yes  [x] No

If so, attached an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.


                               Perrigo Company
                (Name of Registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.


Date: November 17, 1998            By: /s/ Thomas J. Ross
                                      --------------------
                                      Thomas J. Ross
                                      Principal Accounting and Financial Officer







INSTRUCTION:  The form may be signed by an executive officer of the Registrant
or by any other duly authorized representative.  The name and title of the
person signing the form shall be typed or printed beneath the signature.  If
the statement is signed on behalf of the Registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the Registrant shall be filed
with the form.


                                  Attention
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).



                                      3





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission